With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...
NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...
Zacks.com on MSN4d
Medtronic (MDT) Stock Sinks As Market Gains: Here's WhyThe latest trading session saw Medtronic (MDT) ending at $87.72, denoting a -0.45% adjustment from its last day's close. The stock's change was less than the S&P 500's daily gain of 0.38%. Meanwhile, ...
Zacks.com on MSN5d
Medtronic Stock Trading at a Discount Before Q2 Earnings: Time to Buy?Medtronic plc MDT is scheduled to report second-quarter fiscal 2025 results on Nov. 19, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.23 exceeded the ...
A new medical technology fund which focusses on early-stage health technologies is itself an innovation. Utilizing its ...
Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...
We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...
We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...
Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback